Archon Capital Management LLC Neuronetics, Inc. Transaction History

Archon Capital Management LLC

$290 Million
Q1 2024

A detailed history of Archon Capital Management LLC transactions in Neuronetics, Inc. stock. As of the latest transaction made, Archon Capital Management LLC holds 2,537,097 shares of STIM stock, worth $4.57 Million. This represents 4.16% of its overall portfolio holdings.

Number of Shares

2,537,097

Previous 2,537,097 -0.0%

Holding current value

$4.57 Million

Previous $7.36 Million 64.14%

% of portfolio

4.16%

Previous 1.82%

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 13, 2024	SELL	$1.05 - $2.9 $357,639 - $987,766	-340,609 Reduced 11.84%	2,537,097 $7.36 Million
Q3 2023 Nov 13, 2023	BUY	$1.29 - $2.22 $553,344 - $952,266	428,949 Added 17.52%	2,877,706 $3.88 Million
Q2 2023 Aug 11, 2023	BUY	$2.07 - $2.92 $1.5 Million - $2.12 Million	725,007 Added 42.06%	2,448,757 $5.26 Million
Q1 2023 May 12, 2023	SELL	$2.81 - $6.71 $286,777 - $684,795	-102,056 Reduced 5.59%	1,723,750 $5.02 Million
Q2 2022 Aug 15, 2022	BUY	$2.09 - $3.71 $51,875 - $92,085	24,821 Added 1.38%	1,825,806 $5.86 Million

Q1 2022 May 16, 2022	SELL	$2.84 - $4.52 $151,741 - $241,503	-53,430 Reduced 2.88%	1,800,985 $5.46 Million
Q4 2021 Feb 14, 2022	BUY	$3.87 - $6.59 $1.08 Million - $1.84 Million	279,220 Added 17.73%	1,854,415 $8.27 Million
Q3 2021 Nov 15, 2021	BUY	$6.22 - $15.54 $1.56 Million - $3.89 Million	250,000 Added 18.87%	1,575,195 $10.3 Million
Q2 2021 Aug 16, 2021	BUY	$10.15 - $17.25 $1.14 Million - $1.94 Million	112,300 Added 9.26%	1,325,195 $21.2 Million
Q1 2021 May 14, 2021	BUY	$10.6 - $21.27 $1.57 Million - $3.16 Million	148,475 Added 13.95%	1,212,895 $15 Million
Q3 2020 Nov 13, 2020	BUY	$1.82 - $5.87 $1.94 Million - $6.25 Million	1,064,420 New	1,064,420 $5.17 Million

Others Institutions Holding STIM

# of Institutions

Shares Held

18.4M

Call Options Held

200

Put Options Held

3.6K

View Full List

About Neuronetics, Inc.

Ticker STIM
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 27,022,800
Market Cap $48.6M
Description
Neuronetics, Inc., a commercial stage medical technology company, designs, develops, and markets products for patients with neurohealth disorders in the United States and internationally. The company offers NeuroStar Advanced Therapy System, a non-invasive and non-systemic office-based treatment to treat adult patients with major depressive diso...

More about STIM

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Archon Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Archon Capital Management LLC with notifications on news.

Account

Archon Capital Management LLC Neuronetics, Inc. Transaction History